Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7211-7220 Newer>

The Motley Fool February 28, 2011 Brian Orelli	6 Health-Care IPOs; 3 Worth Watching The health-care-company IPO window has cranked wide open over the past few weeks. But investors haven't been all that eager to catch every company jumping through that window.
The Motley Fool February 28, 2011 David Williamson	Don't Miss These Health-Care ETFs Two ways ETFs can help your portfolio
The Motley Fool February 28, 2011 Brian D. Pacampara	Next-Generation Drug Technologies Battle It Out Alnylam and Sangamo BioSciences have different ways to manipulate proteins to fight disease.
The Motley Fool February 28, 2011 Cindy Johnson	Medicis Pharmaceutical Shares Popped: What You Need to Know Medicis Pharmaceutical Corporation popped 26% in intraday trading today after reporting an inline quarter and announcing a licensing agreement with Teva Pharmaceutical Industries.
The Motley Fool February 28, 2011 Seth Jayson	Should You Get Out of Impax Laboratories Before Next Quarter? For the last fully reported fiscal quarter, Impax Laboratories's year-over-year revenue shrank 43.7%, and its AR dropped 55.9%. That looks OK.
The Motley Fool February 27, 2011 Anders Bylund	Buy These 3 Tech Stocks to Hold Forever Google, IBM, and Intuitive Surgical may be those elusive "forever" stocks.
The Motley Fool February 26, 2011 Brian Orelli	FDA Applications and a Look Ahead It isn't pretty.
The Motley Fool February 25, 2011 Brian Orelli	When the Companies Know, Investors Should, Too Why don't more companies preannounce FDA rejections?
The Motley Fool February 25, 2011 Esterhuizen & Sellitti	12 Small-Cap Biotech Stocks Being Snapped Up by Mutual Fund Investors If you're looking for small-cap biotech investing ideas, the following list might offer some good starting points.
The Motley Fool February 25, 2011 Rex Moore	Rising Star Buys: 2 Health Care Winners Abbott Laboratories and Johnson & Johnson are being added to the Motley Fool multivitamin portfolio.
<Older 7211-7220 Newer> Return to current articles.